✦ LIBER ✦

D26 - 24-Hour antihypertensive efficacy of extended release felodipine

✍ Scribed by G Pannarale; PE Puddu; F Monti; F Collauto; G Serafini; M Schiariti; PP Campa

Book ID: 116155773
Publisher: Nature Publishing Group
Year: 1995
Tongue: English
Weight: 178 KB
Volume: 8
Category: Article
ISSN: 0895-7061
DOI: 10.1016/0895-7061(95)97635-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

24-hour non-invasive blood pressure moni

24-hour non-invasive blood pressure monitoring of felodipine-metoprolol extende release tablet

✍ RABBIA, F 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 291 KB

D13 - Acute antihypertensive efficacy an

D13 - Acute antihypertensive efficacy and trough to peak ratios of felodipine er using 24 hour ambulatory monitoring

✍ R.M. Lederle; D Wetzchewald; E Lederle 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 192 KB

Effect of Amlodipine Versus Felodipine E

Effect of Amlodipine Versus Felodipine Extended Release on 24-Hour Ambulatory Blood Pressure in Hypertension

✍ Jan Östergren; Hans Isaksson; Ulf Brodin; Åke Schwan; K.Peter Öhman 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 193 KB

Plasma concentration profiles and antihy

Plasma concentration profiles and antihypertensive effect of conventional and extended-release felodipine tablets.

✍ E Blychert; K Wingstrand; B Edgar; K Lidman 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 852 KB

Twenty-four-hour activity of felodipine

Twenty-four-hour activity of felodipine extended release in chronic stable angina pectoris

✍ Gino Santoro; Stefano Savonitto; Vito Di Bello; Daniele Alberti; Costantino Gius 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 643 KB

Antihypertensive efficacy of twice daily

Antihypertensive efficacy of twice daily controlled release diltiazem using 24 hour intra-arterial blood pressure monitoring

✍ B. S. Sridhara; P. Thomas; A. Lahiri; E. B. Raftery 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 434 KB

The aim of the study was to examine the efficacy of a new controlled release formulation of diltiazem administered in a twice-daily dose in patients with essential hypertension using 24 hour intra-arterial ambulatory blood pressure monitoring. Sixteen patients (2 female) of mean age 53 years with m